logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Review of Anticancer Therapy cover

Expert Review of Anticancer Therapy

IF2.8
Papers312
Citations4123
Journal Papers 284
Publication Date
delete
How zongertinib was developed for HER2-mutant non-small cell lung cancer: a plain language summary
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-10-11
delete0
deleteOAAI
deleteJohn V Heymach; Birgit Wilding
deleteShare
deleteSave
Real-world clinical and economic outcomes in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-10-06
delete0
deleteOAAI
deleteRana R. McKay; Jennifer Nguyen; Barinder Kang; Clare Byrne; Jackson Tang; Kyle Runeckles; Amrita Sawhney; Jeetvan Patel
deleteShare
deleteSave
Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-10-02
delete0
PREAI
deleteAishwarya Rai; Alma Vikram; Tej Pal Singh; Pradeep Sharma; Sujata Sharma
deleteShare
deleteSave
How does adding PD-(L)1 inhibitors to platinum-etoposide treatment of small cell lung cancer improve survival outcomes?
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-27
delete0
deleteOAAI
deleteMaria Giovanna Formelli; Adriana Di Odoardo; Elisa Andrini; Giuseppe Lamberti
deleteShare
deleteSave
Prospective patient preference study for chronic lymphocytic leukemia (CLL) treatment attributes impacting patient shared decision-making
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-23
delete0
deleteOAAI
deleteSikander Ailawadhi; Swetha Challagulla; Yan Meng; Todor I. Totev; Dominic Pilon; Lilian Diaz; Zhuo Chen; Keri Yang
deleteShare
deleteSave
Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-17
delete0
PREAI
deleteSalih Karatlı; Doğan Yazılıtaş; Mustafa Altınbaş
deleteShare
deleteSave
Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-17
delete0
PREAI
deleteAnjali Shah; George John; Anuradha Mehta; Vikas Ostwal; Anant Ramaswamy; Prabhat Bhargava
deleteShare
deleteSave
Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-16
delete0
PREAI
deleteKannan Sridharan; Mattia Alberto Di Civita; Gowri Sivaramakrishnan; Luca Zacco; Wataru Fukuokaya; Takahiro Kimura; Takafumi Yanagisawa; Jindrich Kopecky; Tarek Taha; Gian Paolo Spinelli; Tomas Buchler; Brigida Anna Maiorano; Andrea Malgeri; Linda Cerbone; Fabio Calabrò; Jawaher Ansari; Se Hoon Park; Aristotelis Bamias; Daniele Santini; Matteo Santoni
deleteShare
deleteSave
Salivary duct carcinoma- contemporary nuts and bolts from pathologist perspective
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-16
delete0
PREAI
deleteDiana Bell; Renata Ferraroto; Adel K. El-Naggar
deleteShare
deleteSave
Overcoming emerging challenges in childhood cancer survivorship: a spotlight on pediatric CNS tumors
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-14
delete0
PREAI
deleteElisabetta Schiavello; Veronica Biassoni; Olga Nigro; Fabio Simonetti; Alessandro Cattoni; William Zardo; Andrea Trezza; Giorgio Carrabba; Carlo Giussani; Sabina Vennarini; Silvia Esposito; Francesca Filippi; Monica Terenziani; Maura Massimino
deleteShare
deleteSave
The role of chemotherapy in high-risk gestational trophoblastic neoplasia
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-10
delete0
PREAI
deleteAntonio Braga; Gabriela Paiva; Manisha Asrani; Jessica St. Laurent; Ross Berkowitz; Neil Horowitz
deleteShare
deleteSave
Fertility preservation in women with central nervous system tumors
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-09
delete0
PREAI
deleteAlicia Tosoni; Chiara Gorbi; Maurizio Mascarin; Elisa Coassin; Diego Raimondo; Marisol Doglioli; Rossella Vicenti; Vincenzo Di Nunno; Lidia Gatto; Stefania Bartolini; Renato Seracchioli; Enrico Franceschi
deleteShare
deleteSave
Regulatory and scientific challenges in pediatric oncology
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-09
delete0
PREAI
deleteStefania Bellino; Daniela Lucente; Anna La Salvia
deleteShare
deleteSave
Key barriers in utilizing advanced T-cell engager strategies on solid tumors
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-09-07
delete0
PREAI
deleteBo Mi Ku; Sung-Won Lim; Jieun Uhm; Byeong-Bae Park; Myung-Ju Ahn
deleteShare
deleteSave
The primary care-oncology interface is now a patient safety frontier
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-08-26
delete0
deleteOAAI
deleteWaseem Jerjes
deleteShare
deleteSave
Access is not enough: the deliverability gap in modern oncology
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-08-25
delete0
deleteOAAI
deleteWaseem Jerjes
deleteShare
deleteSave
From fragmentation to focus: building collaborative networks for rare cancer research – the Italian TYME network as a model for care and innovation?
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-08-25
delete0
PREAI
deleteAnnalisa Trama; Giuseppe Lo Russo; Monica Ganzinelli; Laura Abate-Daga; Tommaso Martino De Pas; Paolo Mendogni; Rossana Berardi; Davide Franceschini; Lorenzo Rosso; Giovannella Palmieri; Iacopo Petrini; Giulia Pasello; Fiorella Calabrese; Giovanni Maria Comacchio; Fabiana Letizia Cecere; Mirella Marino; Enrico Ruffini; Marina Chiara Garassino; Paraskevas Lyberis; Andrea Dell’Amore; Giulia Galli; Paolo Andrea Zucali
deleteShare
deleteSave
Conversion surgery for advanced biliary tract cancer in the era of molecularly targeted therapy and immunotherapy: from unresectable disease to multidisciplinary curative strategy
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-08-24
delete0
PREAI
deleteTakehiro Okabayashi; Motoyasu Tabuchi; Teppei Tokumaru; Sunao Uemura; Shuta Tamura
deleteShare
deleteSave
AA amyloidosis as a renal immune-related adverse event of immune checkpoint inhibitors: mechanisms, diagnosis, and management
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-08-17
delete0
PREAI
deleteOzgur Tanriverdi
deleteShare
deleteSave
Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing
deleteExpert Review of Anticancer Therapy
IF2.8
delete2026-08-07
delete0
PREAI
deleteElhadi Iich; Bavani Kannan; Yi Chye Law; Jason Yongsheng Chan
deleteShare
deleteSave